Sarah Boyce Insider Trading $AKCA AKCEA THERAPEUTICS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Sarah Boyce.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Sarah Boyce. Sarah Boyce is Director in LIGAND PHARMACEUTICALS INC ($LGND) and Chief Business Officer in IONIS PHARMACEUTICALS INC ($ISIS) and President and CEO in Avidity Biosciences, Inc. ($RNA) and President in AKCEA THERAPEUTICS, INC. ($AKCA) and Director in Berkeley Lights, Inc. ($BLI).

Sarah Boyce in AKCEA THERAPEUTICS, INC.

Trading Symbol: AKCA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sarah Boyce: President
Holdings: 19,888 shares
Latest Transaction: Jul 17 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Sarah Boyce in AKCEA THERAPEUTICS, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AKCA, RNA, BLI, ISIS, LGND

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jul 17 2019	AKCA	AKCEA THERAPEUTICS ...	Boyce Sarah	President	Sell	S	23.52	1,819	42,783	19,888	21.7 K to 19.9 K (-8.38 %)
Jul 03 2019	AKCA	AKCEA THERAPEUTICS ...	Boyce Sarah	President	Grant	A	20.04	813	16,295	21,707	20.9 K to 21.7 K (+3.89 %)
Jan 04 2019	AKCA	AKCEA THERAPEUTICS ...	Boyce Sarah	President	Option Exercise	A	30.73	173,000	5,316,290	173,000
Apr 18 2018	AKCA	AKCEA THERAPEUTICS ...	Boyce Sarah	President	Option Exercise	A	23.93	1,000,000	23,930,000	1,000,000
Apr 18 2018	AKCA	AKCEA THERAPEUTICS ...	Boyce Sarah	President	Grant	A	0.00	20,894	0	20,894	0 to 20.9 K

Page: 1